Original Research
Accepted on 23 Dec 2025
BROMHEXINE INHIBITS SARS-CoV-2 OMICRON AND VARIANT PSEUDOVIRUS INFECTION VIA ACE2-TARGETED MECHANISMS
in Experimental Pharmacology and Drug Discovery
- 153 views
Original Research
Accepted on 23 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 23 Dec 2025
in Pharmacoepidemiology
Original Research
Accepted on 22 Dec 2025
in Ethnopharmacology
Case Report
Accepted on 22 Dec 2025
in Respiratory Pharmacology
Original Research
Accepted on 22 Dec 2025
in Pharmacogenetics and Pharmacogenomics
Systematic Review
Accepted on 22 Dec 2025
in Ethnopharmacology
Correction
Accepted on 22 Dec 2025
in Ethnopharmacology
Original Research
Accepted on 22 Dec 2025
in Neuropharmacology
Original Research
Accepted on 22 Dec 2025
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 22 Dec 2025
in Drug Metabolism and Transport
Original Research
Accepted on 22 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 22 Dec 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 22 Dec 2025
in Ethnopharmacology
Original Research
Accepted on 22 Dec 2025
in Ethnopharmacology
Original Research
Accepted on 22 Dec 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 22 Dec 2025
in Inflammation Pharmacology
Review
Accepted on 22 Dec 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 22 Dec 2025
in Drug Metabolism and Transport
Review
Accepted on 22 Dec 2025
in Ethnopharmacology
Review
Accepted on 22 Dec 2025
in Ethnopharmacology
Original Research
Accepted on 22 Dec 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 22 Dec 2025
in Experimental Pharmacology and Drug Discovery
General Commentary
Accepted on 22 Dec 2025
in Renal Pharmacology
Review
Accepted on 22 Dec 2025
in Ethnopharmacology